Safety and Pharmacokinetics of Indacaterol in Healthy Subjects and Those With Impaired Liver Function
NCT00416702
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
32
Enrollment
INDUSTRY
Sponsor class
Conditions
Hepatic Insufficiency
Interventions
DRUG:
QAB149
Sponsor
Novartis